SG11201501902RA - Isoxazolidine derivatives - Google Patents

Isoxazolidine derivatives

Info

Publication number
SG11201501902RA
SG11201501902RA SG11201501902RA SG11201501902RA SG11201501902RA SG 11201501902R A SG11201501902R A SG 11201501902RA SG 11201501902R A SG11201501902R A SG 11201501902RA SG 11201501902R A SG11201501902R A SG 11201501902RA SG 11201501902R A SG11201501902R A SG 11201501902RA
Authority
SG
Singapore
Prior art keywords
isoxazolidine derivatives
isoxazolidine
derivatives
Prior art date
Application number
SG11201501902RA
Inventor
Eleonora Ghidini
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47044778&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201501902R(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of SG11201501902RA publication Critical patent/SG11201501902RA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0057Nitrogen and oxygen
    • C07J71/0068Nitrogen and oxygen at position 16(17)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SG11201501902RA 2012-09-13 2013-08-23 Isoxazolidine derivatives SG11201501902RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12184286 2012-09-13
PCT/EP2013/067509 WO2014040837A1 (en) 2012-09-13 2013-08-23 Isoxazolidine derivatives

Publications (1)

Publication Number Publication Date
SG11201501902RA true SG11201501902RA (en) 2015-04-29

Family

ID=47044778

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201501902RA SG11201501902RA (en) 2012-09-13 2013-08-23 Isoxazolidine derivatives

Country Status (28)

Country Link
US (2) US9155747B2 (en)
EP (1) EP2895495B1 (en)
JP (2) JP2015533801A (en)
KR (1) KR101719524B1 (en)
CN (2) CN108440637A (en)
AR (1) AR092547A1 (en)
AU (1) AU2013314539B2 (en)
BR (1) BR112015005500B1 (en)
CA (1) CA2884705C (en)
CL (1) CL2015000610A1 (en)
EA (1) EA027034B1 (en)
ES (1) ES2672140T3 (en)
GE (1) GEP201706708B (en)
HK (1) HK1209756A1 (en)
IL (1) IL237686A (en)
MA (1) MA37927B2 (en)
MX (1) MX364865B (en)
MY (1) MY182523A (en)
NZ (1) NZ705902A (en)
PE (1) PE20150675A1 (en)
PH (1) PH12015500534B1 (en)
PL (1) PL2895495T3 (en)
SA (1) SA515360134B1 (en)
SG (1) SG11201501902RA (en)
TN (1) TN2015000093A1 (en)
UA (1) UA116545C2 (en)
WO (1) WO2014040837A1 (en)
ZA (1) ZA201501691B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103391945B (en) 2011-03-15 2016-11-09 奇斯药制品公司 Isoxazolidine derivant
CA3128468A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
CN115785188A (en) * 2022-12-20 2023-03-14 湖南醇健制药科技有限公司 Preparation method of budesonide

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL31997A (en) * 1968-05-03 1974-03-14 Lepetit Spa Process for the preparation of pregnano(17alpha,16alpha-d)oxazolines and 16alpha,21-dihydroxy-17alpha-aminopregnanes
SE378110B (en) * 1972-05-19 1975-08-18 Bofors Ab
JPS617293A (en) * 1984-06-20 1986-01-13 Mitsubishi Chem Ind Ltd Novel corticoid derivative and preparation thereof
US5888995A (en) * 1991-02-04 1999-03-30 Astra Aktiebolag Steroid esters
AU2003217535A1 (en) * 2002-02-20 2003-09-09 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids
WO2005028495A1 (en) * 2003-09-24 2005-03-31 Glaxo Group Limited Anti-inflammatory glucocorticoids
NO331891B1 (en) * 2007-03-20 2012-04-30 Clavis Pharma Asa Chemical compounds, a pharmaceutical composition containing such compounds, and their use for the treatment of cancer, inflammation and COPD
MX2010009022A (en) * 2008-02-27 2010-09-07 Astrazeneca Ab 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use.
WO2011029547A2 (en) * 2009-09-11 2011-03-17 Chiesi Farmaceutici S.P.A. Pregnane derivatives condensed in the 16, 17 position with an n-substituted isoxazolidine ring as anti-inflammatory agents
TW201139369A (en) 2010-02-05 2011-11-16 Chiesi Farma Spa Pyrrolidine derivatives
CN103391945B (en) 2011-03-15 2016-11-09 奇斯药制品公司 Isoxazolidine derivant
RU2013141933A (en) 2011-03-15 2015-03-20 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. ISOXAZOLIDINE DERIVATIVES
KR20140042886A (en) 2011-08-01 2014-04-07 키에시 파르마슈티시 엣스. 피. 에이. Anti-inflammatory steroids condensed in position 16,17 with pyrrolidine ring

Also Published As

Publication number Publication date
PL2895495T3 (en) 2018-10-31
MY182523A (en) 2021-01-25
MX2015002898A (en) 2015-06-03
JP2015533801A (en) 2015-11-26
EA027034B1 (en) 2017-06-30
GEP201706708B (en) 2017-07-25
CN108440637A (en) 2018-08-24
JP6736607B2 (en) 2020-08-05
SA515360134B1 (en) 2016-07-24
AU2013314539B2 (en) 2018-03-08
KR101719524B1 (en) 2017-03-24
MA20150350A1 (en) 2015-10-30
US20150376226A1 (en) 2015-12-31
PE20150675A1 (en) 2015-05-20
US9469669B2 (en) 2016-10-18
TN2015000093A1 (en) 2016-06-29
JP2018162270A (en) 2018-10-18
ZA201501691B (en) 2016-10-26
EP2895495A1 (en) 2015-07-22
BR112015005500A2 (en) 2018-05-22
PH12015500534A1 (en) 2015-05-04
CA2884705A1 (en) 2014-03-20
MX364865B (en) 2019-05-09
PH12015500534B1 (en) 2015-05-04
US9155747B2 (en) 2015-10-13
UA116545C2 (en) 2018-04-10
CA2884705C (en) 2021-04-13
AU2013314539A1 (en) 2015-04-02
CN104619714A (en) 2015-05-13
IL237686A (en) 2017-10-31
AR092547A1 (en) 2015-04-22
HK1209756A1 (en) 2016-04-08
MA37927B2 (en) 2021-08-31
CL2015000610A1 (en) 2015-12-04
ES2672140T3 (en) 2018-06-12
NZ705902A (en) 2018-04-27
WO2014040837A1 (en) 2014-03-20
EA201590390A1 (en) 2015-08-31
US20140069419A1 (en) 2014-03-13
KR20150042264A (en) 2015-04-20
BR112015005500B1 (en) 2022-11-22
EP2895495B1 (en) 2018-05-16

Similar Documents

Publication Publication Date Title
HUS2200040I1 (en) Benzimidazole-proline derivatives
HK1205740A1 (en) Pyrrolotriazinone derivatives
HK1207375A1 (en) Piperidinylpyrazolopyridine derivative
HK1205508A1 (en) New bicyclicpyridine derivatives
IL236295A (en) Indanesulfamide derivative
ZA201502175B (en) Oxazolidin-2-one-pyrimidine derivatives
RS56703B1 (en) New phenyl-tetrahydroisoquinoline derivatives
ZA201405681B (en) Isoxazolidine derivatives
HK1209756A1 (en) Isoxazolidine derivatives
PL2873660T3 (en) Indolecarboxamide derivative
SG11201404325VA (en) Pyrimidooxazocine derivatives as mtor - inhibitors
EP2842958A4 (en) Naphthobisthiadiazole derivative
HK1204621A1 (en) 4-alkanoylamino-3-pyrazolone derivative 4--3-